Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

UPBUpstream Bio, Inc.

Nasdaq · CIK 0002022626
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts192

Identity from submissions API

NameUpstream Bio, Inc.
CIK0002022626
TickersUPB
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone781-208-2466
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
890 WINTER STREET, SUITE 200
WALTHAM
MA
02451
MA
Mailing address
890 WINTER STREET, SUITE 200
WALTHAM
MA
02451
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

137 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-10 10-Q 10-Q 0001193125-26-454422 001-42366 261537925 34 10378717 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-454405 001-42366 261537905 34 403628 1 1
2026-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002943 005-94651 261529781 34 11448
2026-10-29 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001834150-26-000006 005-94651 261501960 34 14047
2026-09-17 4 4 0001193125-26-394322 4969
2026-09-17 4 4 0001193125-26-394318 4978
2026-09-17 4 4 0001193125-26-394330 4999
2026-09-17 4 4 0001193125-26-394325 4980
2026-09-17 4 4 0001193125-26-394324 5002
2026-09-01 8-K 8-K 7.01,8.01,9.01 0001193125-26-377485 001-42366 261348501 34 238902 1 1
2026-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001374170-26-000067 005-94651 261265240 34 7589
2026-08-11 10-Q 10-Q 0001193125-26-343417 001-42366 261260594 34 9625685 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-343407 001-42366 261260582 34 401960 1 1
2026-07-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003119 005-94651 261221147 34 10841
2026-06-17 4 4 0001193125-26-274126 4968
2026-06-17 4 4 0001193125-26-274125 4979
2026-06-17 4 4 0001193125-26-274122 5001
2026-06-17 4 4 0001193125-26-274121 5189
2026-06-17 4 4 0001193125-26-274119 4977
2026-06-11 4 4 0001193125-26-268169 5376
2026-06-11 4 4 0001193125-26-268168 5388
2026-06-11 4 4 0001193125-26-268167 5795
2026-06-11 4 4 0001193125-26-268166 5395
2026-06-11 4 4 0001193125-26-268165 5382
2026-06-11 4 4 0001193125-26-268164 6039
2026-06-10 8-K 8-K 5.07 0001193125-26-265800 001-42366 261079637 34 178165 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001834150-26-000003 005-94651 26987650 34 14446
2026-05-13 10-Q 10-Q 0001193125-26-220584 001-42366 26970901 34 8620681 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001193125-26-220578 001-42366 26970885 34 362928 1 1
2026-04-16 ARS ARS 0001193125-26-159033 001-42366 26867742 34 8357438
2026-04-16 DEFA14A DEFA14A 0001193125-26-159006 001-42366 26867646 34 1217817
2026-04-16 DEF 14A DEF 14A 0001193125-26-158966 001-42366 26867524 34 2905233 1 1
2026-03-26 8-K 8-K 1.01,9.01 0001193125-26-126572 001-42366 26799268 34 457160 1 1
2026-03-26 424B5 424B5 0001193125-26-126561 333-291267 26799220 33 1400474 1 1
2026-03-26 S-8 S-8 0001193125-26-126342 333-294646 26798634 33 245199 1 1
2026-03-26 10-K 10-K 0001193125-26-126188 001-42366 26798045 34 52040509 1 1
2026-03-26 8-K 8-K 2.02,9.01 0001193125-26-125057 001-42366 26794303 34 426371 1 1
2026-03-17 4 4 0001193125-26-111138 4831
2026-03-17 4 4 0001193125-26-111134 4861
2026-03-17 4 4 0001193125-26-111124 4842
2026-03-17 4 4 0001193125-26-111121 4840
2026-03-17 4 4 0001193125-26-111105 4864
2026-02-11 8-K 8-K 2.02,7.01,9.01 0001193125-26-045649 001-42366 26618655 34 3009623 1 1
2026-02-11 8-K 8-K 7.01,8.01,9.01 0001193125-26-045500 001-42366 26618295 34 186074 1 1
2026-01-06 4 4 0001193125-26-004758 7107
2026-01-06 4 4 0001193125-26-004757 7328
2026-01-06 4 4 0001193125-26-004756 7116
2026-01-06 4 4 0001193125-26-004755 7140
2026-01-06 4 4 0001193125-26-004754 7120
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-283082 005-94651 251486920 34 12726
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112485 005-94651 251485846 34 7400
2025-11-05 S-3ASR S-3ASR 0001193125-25-265752 333-291267 251451798 33 1131618 1 1
2025-11-05 10-Q 10-Q 0001193125-25-265713 001-42366 251451758 34 10156692 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-265705 001-42366 251451744 34 412490 1 1
2025-10-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001374170-25-000084 005-94651 251416697 34 6517
2025-09-02 8-K 8-K 7.01,8.01,9.01 0002022626-25-000005 001-42366 251283123 34 2192157 1 1
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002129 005-94651 251188509 34 11174
2025-08-06 10-Q 10-Q 0000950170-25-103534 001-42366 251187432 34 9960268 1 1
2025-08-06 8-K 8-K 2.02,9.01 0000950170-25-103528 001-42366 251187410 34 409684 1 1
2025-06-12 8-K 8-K 5.07 0000950170-25-085374 001-42366 251042743 34 177706 1 1
2025-06-12 4 4 0000950170-25-085373 13416
2025-06-12 4 4 0000950170-25-085371 14020
2025-06-12 4 4 0000950170-25-085382 13419
2025-06-12 4 4 0000950170-25-085381 13423
2025-06-12 4 4 0000950170-25-085372 13823
2025-06-12 4 4 0000950170-25-085370 13410
2025-05-06 10-Q 10-Q 0000950170-25-063957 001-42366 25915209 34 8731296 1 1
2025-05-06 8-K 8-K 2.02,9.01 0000950170-25-063954 001-42366 25915193 34 363176 1 1
2025-04-17 ARS ARS 0000950170-25-055399 001-42366 25847483 34 7192560
2025-04-17 DEFA14A DEFA14A 0000950170-25-055385 001-42366 25847393 34 531235
2025-04-17 DEF 14A DEF 14A 0000950170-25-055372 001-42366 25847251 34 1566124
2025-03-12 S-8 S-8 0000950170-25-037623 333-285729 25729981 33 103980
2025-03-12 10-K 10-K 0000950170-25-037621 001-42366 25729978 34 54327768 1 1
2025-03-12 8-K 8-K 2.02,9.01 0000950170-25-037619 001-42366 25729969 34 394576 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004199 005-94651 25631329 34 18848
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021267 005-94651 25629363 34 117572
2025-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-012954 005-94651 25620498 34 7224
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-000914 005-94651 25612628 34 11543
2025-02-07 4 4 0000950170-25-016471 13878
2025-02-07 4 4 0000950170-25-016469 11239
2025-02-07 4 4 0000950170-25-016467 13666
2025-02-07 4 4 0000950170-25-016466 13663
2025-02-07 4 4 0000950170-25-016460 5237
2024-12-17 4 4 0000950170-24-137213 5291
2024-12-17 3 3 0000950170-24-137198 17298
2024-11-07 SC 13G filing.txt 0000315066-24-002584 005-94651 241433517 34 8116
2024-11-07 10-Q 10-Q 0000950170-24-122793 001-42366 241433157 34 9259413 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-122784 001-42366 241433127 34 359785 1 1
2024-10-22 SC 13D SC 13D 0001193125-24-241045 005-94651 241386392 34 180049
2024-10-18 SC 13G SC 13G 0001193125-24-239740 005-94651 241381615 34 50337
2024-10-17 4 xslF345X05/ownership.xml 0000947871-24-000807 21729
2024-10-17 4 xslF345X05/ownership.xml 0000947871-24-000806 27331
2024-10-17 SC 13D SCHEDULE 13D 0000947871-24-000805 005-94651 241377773 34 144245
2024-10-17 4 4 0000950170-24-115295 19569
2024-10-16 SEC STAFF LETTER filename1.pdf 9999999997-24-004125 62969
2024-10-15 4 4 0000950170-24-114802 7159
2024-10-15 4 4 0000950170-24-114685 5857
2024-10-15 4 4 0000950170-24-114684 5255
2024-10-15 4 4 0000950170-24-114687 5252
2024-10-15 4 4 0000950170-24-114683 5660
2024-10-15 4 4 0000950170-24-114686 5211
2024-10-15 4 4 0000950170-24-114681 5246
2024-10-15 8-K 8-K 5.03,9.01 0001193125-24-237580 001-42366 241371879 34 171602
2024-10-11 S-8 S-8 0001193125-24-236733 333-282614 241367795 33 86916
2024-10-11 424B4 424B4 0001193125-24-236714 333-282197 241367604 33 8123560
2024-10-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-10-10 16:01:00 9999999995-24-003150 333-282197 241366236 33 1721
2024-10-10 3 3 0000950170-24-114166 4774
2024-10-10 3 3 0000950170-24-114164 19281
2024-10-10 3 3 0000950170-24-114162 26054
2024-10-10 3 3 0000950170-24-114160 16615
2024-10-10 3 3 0000950170-24-114158 23063
2024-10-10 3 3 0000950170-24-114155 20772
2024-10-10 3 3 0000950170-24-114154 18175
2024-10-10 3 3 0000950170-24-114151 23693
2024-10-10 3 3 0000950170-24-114149 16865
2024-10-10 3 3 0000950170-24-114148 17506
2024-10-10 3 3 0000950170-24-114147 21319
2024-10-10 3 3 0000950170-24-114146 19752
2024-10-10 S-1MEF S-1MEF 0001193125-24-236086 333-282592 241366074 33 64114
2024-10-10 3 3 0000950170-24-114084 26995
2024-10-10 CERT 8A_Cert_UPB.pdf 0001354457-24-000757 001-42366 241364758 34 761486
2024-10-08 8-A12B 8-A12B 0001193125-24-234377 001-42366 241360381 34 15438
2024-10-08 CORRESP filename1.htm 0001193125-24-234373 9727
2024-10-08 CORRESP filename1.htm 0001193125-24-234371 6645
2024-10-07 S-1/A S-1/A 0001193125-24-233296 333-282197 241356049 33 9247805
2024-09-30 CORRESP filename1.htm 0001193125-24-228326 109644
2024-09-18 CORRESP filename1.htm 0001193125-24-221382 26459
2024-09-18 S-1 S-1 0001193125-24-221372 333-282197 241307511 33 11649025
2024-08-20 UPLOAD filename1.pdf 0000000000-24-009514 377-07271 42659
2024-08-09 DRSLTR filename1.htm 0000950123-24-007586 34530
2024-08-09 DRS/A filename1.htm 0000950123-24-007584 377-07271 241190989 33 8175426
2024-07-25 UPLOAD filename1.pdf 0000000000-24-008469 377-07271 46394
2024-07-18 DRSLTR filename1.htm 0000950123-24-006650 59958
2024-07-18 DRS/A filename1.htm 0000950123-24-006649 377-07271 241125427 33 8734939
2024-07-09 SEC STAFF LETTER filename1.pdf 9999999997-24-003209 63398
2024-07-09 UPLOAD filename1.pdf 0000000000-24-007775 377-07271 59040
2024-06-12 DRS filename1.htm 0000950123-24-006208 377-07271 241038317 33 8812185

Latest XBRL company facts

One latest value per concept from companyfacts (192 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 54.81M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
dei EntityPublicFloat Entity Public Float USD 467.86M 2025-06-30 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.38M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 395,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 8.84M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 763,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 492,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -327,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 689.96M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.34M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 13.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 9.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 16,801 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap Assets Assets USD 245.99M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AssetsCurrent Assets, Current USD 244.63M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 331,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 160.28M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 153.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 159.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 47.42M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 47.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 47.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -54.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 86.00M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 39.61M 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122793
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 54.81M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 54.81M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap CommonStockValue Common Stock, Value, Issued USD 54,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -122.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 1 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122793
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 479,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2024-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 104.11M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 479,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 19.92M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 6.62M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.83M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 103.63M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 145,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 148,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.23 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.225 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.003 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 4.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 36.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 22.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap Goodwill Goodwill USD 0 2024-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 32.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -30.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -83,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap IncreaseDecreaseInAccountsAndNotesReceivable Increase (Decrease) in Accounts and Notes Receivable USD -273,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -341,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 616,000 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122793
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -480,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -1.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 27.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 16.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 7.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap LeaseCost Lease, Cost USD 739,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 1.40M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 700,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 800,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 800,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 134,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap Liabilities Liabilities USD 12.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 245.99M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap LiabilitiesCurrent Liabilities, Current USD 11.96M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap LineOfCredit Long-term Line of Credit USD 200,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ManufacturingCosts Manufacturing Costs USD 11.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 3.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 80.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -137.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -121.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -143.44M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 7.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OperatingExpenses Operating Expenses USD 131.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -129.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OperatingLeaseCost Operating Lease, Cost USD 739,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.27M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 732,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 57,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OperatingLeasePayments Operating Lease, Payments USD 742,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 754,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.117 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap OtherAssetsCurrent Other Assets, Current USD 792,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -857,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -857,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 3.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 55,000 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-265713
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.57M 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220584
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 3.90M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 81.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 33.32M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.05 2023-06-01 2023-06-30 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 36.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 34.81M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PrepaidInsurance Prepaid Insurance USD 10,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 100.00M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122793
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 2.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 400.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 670.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 161.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 598,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220584
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 1.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -121.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 903,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 411,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 109.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 194,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -455.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 2.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 13.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.939 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.85 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 43,667 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 1.10M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 3.82 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-122793
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 419,484 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 15.42 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 3.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.33M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 9.21 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 3.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 9.33M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 9.21 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.79 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 10.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 19.13 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 20 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap SharePrice Share Price USD/shares 9.11 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-265713
us-gaap ShortTermInvestments Short-term Investments USD 159.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 233.97M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.049 2024-10-04 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 240,310 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 380.87M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 196,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 598,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-220584
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 267.72M 2023-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 31.76M 2023-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 22.94M 2023-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 22.94M 2023-12-31 2024 FY 10-K 2025-03-12 0000950170-25-037621
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 42.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126188
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 54.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 54.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454422

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →